United States

Celator Pharmaceuticals Inc (CPXX)

Track

Ticker: CPXX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Morenstein Scott D Non-Executive Director
Transaction date
Purchase
Price
424.20
Quantity 60,227 -48.2%
Value US$4,329,480
Jackson Scott Thomas Chief Executive Officer Executive Director
Transaction date
Purchase
Price
315.88
Quantity 36,289 +40.2%
Value US$4,624,621
Powell Fred M VP and Chief Financial Officer Officer
Transaction date
Purchase
Price
470.91
Quantity 14,802 +1.1%
Value US$3,300,932
Valence Life Sciences GP II LLC
Transaction date
Purchase
Price
1.64
Quantity 2,000 +1.2%
Value US$3,280
Valence Life Sciences GP II LLC
Transaction date
Purchase
Price
1.66
Quantity 3,000 +1.8%
Value US$4,980
Valence Life Sciences GP II LLC
Transaction date
Purchase
Price
1.68
Quantity 2,000 +1.2%
Value US$3,360
Valence Life Sciences GP II LLC
Transaction date
Purchase
Price
1.62
Quantity 5,000 +3.1%
Value US$8,100
Valence Life Sciences GP II LLC
Transaction date
Purchase
Price
1.67
Quantity 200 +0.1%
Value US$334
DOUGHERTY MICHAEL R Non-Executive Director
Transaction date
Purchase
Price
2.15
Quantity 20,000 +inf%
Value US$42,940
Powell Fred M Chief Financial Officer Officer
Transaction date
Purchase
Price
2.20
Quantity 6,000 +120.0%
Value US$13,200
Jackson Scott Thomas Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.20
Quantity 10,000 +333.3%
Value US$22,000
Powell Fred M Chief Financial Officer Officer
Transaction date
Purchase
Price
2.50
Quantity 2,500 +100.0%
Value US$6,240
Jackson Scott Thomas Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.50
Quantity 3,000 +inf%
Value US$10,490
Powell Fred M VP and CFO Officer
Transaction date
Purchase
Price
3.50
Quantity 2,500 +inf%
Value US$8,750
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-12-07 2015-12-03 B Purchase Morenstein Scott D Non-Executive Director
60,227 -48.2%
424.20
US$4,329,480 		60,227 -48.2% 424.20 US$4,329,480
2015-10-07 2015-10-06 B Purchase Jackson Scott Thomas

Chief Executive Officer

Executive Director
36,289 +40.2%
315.88
US$4,624,621 		36,289 +40.2% 315.88 US$4,624,621
2015-10-05 2015-10-05 B Purchase Powell Fred M

VP and Chief Financial Officer

Officer
14,802 +1.1%
470.91
US$3,300,932 		14,802 +1.1% 470.91 US$3,300,932
2015-10-02 2015-10-01 B Purchase Valence Life Sciences GP II LLC
2,000 +1.2%
1.64
US$3,280 		2,000 +1.2% 1.64 US$3,280
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
3,000 +1.8%
1.66
US$4,980 		3,000 +1.8% 1.66 US$4,980
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
2,000 +1.2%
1.68
US$3,360 		2,000 +1.2% 1.68 US$3,360
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
5,000 +3.1%
1.62
US$8,100 		5,000 +3.1% 1.62 US$8,100
2015-10-02 2015-09-30 B Purchase Valence Life Sciences GP II LLC
200 +0.1%
1.67
US$334 		200 +0.1% 1.67 US$334
2014-11-20 2014-11-18 B Purchase DOUGHERTY MICHAEL R Non-Executive Director
20,000 +inf%
2.15
US$42,940 		20,000 +inf% 2.15 US$42,940
2014-11-18 2014-11-18 B Purchase Powell Fred M

Chief Financial Officer

Officer
6,000 +120.0%
2.20
US$13,200 		6,000 +120.0% 2.20 US$13,200
2014-11-18 2014-11-18 B Purchase Jackson Scott Thomas

Chief Executive Officer

Executive Director
10,000 +333.3%
2.20
US$22,000 		10,000 +333.3% 2.20 US$22,000
2014-05-16 2014-05-15 B Purchase Powell Fred M

Chief Financial Officer

Officer
2,500 +100.0%
2.50
US$6,240 		2,500 +100.0% 2.50 US$6,240
2013-12-17 2013-12-17 B Purchase Jackson Scott Thomas

Chief Executive Officer

Executive Director
3,000 +inf%
3.50
US$10,490 		3,000 +inf% 3.50 US$10,490
2013-12-17 2013-12-17 B Purchase Powell Fred M

VP and CFO

Officer
2,500 +inf%
3.50
US$8,750 		2,500 +inf% 3.50 US$8,750
Explore more

More insider trading research around Celator Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America